.jpeg "Study Flags Quality Failures in Indian-Made Chemotherapy Drugs")
A new study has shown that many widely used generic chemotherapy medicines around the world have failed quality testing. This raises serious doubts about the safety and efficacy of cancer therapy in more than 100 countries. The affected drugs...
Hyderabad-based Aurobindo Pharma has made a milestone in its biosimilar growth plans, when its subsidiary CuraTeQ Biologics s.r.o. received clearance by the UK's Medicines and Healthcare products Regulatory Agency
As global pressure and expectations increase with the drug quality, Indian pharma has to become intolerant to non-compliance with Good Manufacturing Practice (GMP), stressed Mahantesh Wali, Regulatory Affairs Head at Maiva Pharma.
The Union Health Ministry is looking to tighten drug quality regulations by proposing to immediately suspend manufacturing licenses of pharmaceutical companies for drugs that fail government lab testing. The change follows a recommendation from...
Pharmaceuticals Export Promotion Council of India (Pharmexcil) has assigned two honorary advisors to provide assistance to export pharmaceutical producers with regulatory issues surrounding Foreign Trade Policy (FTP) permitting and other matters...
Hyderabad-based Bharat Biotech and multinational pharmaceutical Corporation GlaxoSmithKline (GSK) have reached an agreement to make the world-first malaria vaccine, Mosquirix (RTS,S), affordable and more readily available to citizens of malar...
Apollo Cancer Centres (ACCs) announced the creation of "CanWin," a cancer support network that unites everyone in their cancer journey, as a major step towards commemorating National Cancer Survivors Month.
According to Telix Pharmaceuticals Limited, a biopharmaceutical company based in Melbourne that specializes in the development and marketing of therapeutic and diagnostic radiopharmaceuticals as well as related medical technologies
Lupin Limited, a multinational pharmaceutical company based in Mumbai, informed that it has received final approval from the US FDA for its Abbreviated New Drug Application (ANDA) on Prucalopride Tablets 1 mg and 2 mg.
Dr Lal PathLabs has enhanced its genomic capabilities by acquiring Illumina's NovaSeq X Series to the dedicated genomics division Genevolve. This additional technology expands the lab's ability to provide rapid and reliable genomic information for...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")